[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![RedChip Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::25292321.png) RedChip [@RedChip](/creator/twitter/RedChip) on x 5578 followers
Created: 2025-07-18 13:20:01 UTC

🎙️ Investor Spotlight: Enlivex Therapeutics $ENLV CEO Shares Game Changing Vision in New Interview

Oren Hershkovitz, CEO of @EnlivexT, dives into the company’s innovative approach to immunotherapy with Allocetra™, a macrophage reprogramming cell therapy targeting high-need indications like osteoarthritis and autoimmune diseases.

💡 Why Investors Should Watch:
🔬 Strong Clinical Data: Statistically significant 6-month results in knee osteoarthritis show sustained pain reduction and functional gains.
💰 High-Value Pipeline: Expansion into basal thumb osteoarthritis and psoriatic arthritis unlocks multi-billion-dollar market potential.
🧠 Proven Leadership: Team led a $560M exit (PROLOR Biotech) and holds strategic ties with Pfizer.
💵 Cash Runway: Funded through 2026 with analyst price targets up to $9.50/share.

📽️ Don’t miss this exclusive look into $ENLV's path to redefining chronic disease treatment.
🔗 Watch the full interview here:

$ENLV $JNJ $ABBV $MRK $AZN #ENLV #BiotechStocks #Immunotherapy #HealthcareInnovation #Osteoarthritis #ClinicalTrials #InvestorUpdate #PharmaNews


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946198273007530012/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[$enlv](/topic/$enlv)
[investment](/topic/investment)
[$issc](/topic/$issc)

[Post Link](https://x.com/RedChip/status/1946198273007530012)